Osteoarthritis Therapeutics Market Report 2026

Osteoarthritis Therapeutics Market Overview

• Osteoarthritis Therapeutics market size has reached to $8.87 billion in 2025 • Expected to grow to $13.21 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market • Market Trend: Innovative Advances In Osteoarthritis Therapeutics With The Launch Of The NITRO Program • North America was the largest region in 2025.

What Is Covered Under Osteoarthritis Therapeutics Market?

Osteoarthritis therapeutics refer to the medical treatments and interventions used to manage and alleviate the symptoms of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage and the underlying bone. These therapeutics include medications, physical therapies, lifestyle modifications, and in some cases, surgical procedures. The primary goals of osteoarthritis therapeutics are to reduce pain, improve joint function, and enhance the quality of life for individuals affected by the condition. The main drug types of osteoarthritis therapeutics are viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, and others. Viscosupplementation agents are treatments injected directly into the joint to help lubricate and cushion it, providing relief from pain and improving mobility. The anatomy includes knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and others, and the different routes of administration are parenteral route, topical route, and oral route. The various sales channels are prescription drugs and over-the-counter drugs, and they are used by various end-users such as hospital pharmacies, retail pharmacies, and others.

What Is The Osteoarthritis Therapeutics Market Growth Forecast?

The osteoarthritis therapeutics market size is expected to see strong growth in the next few years. It will grow to $13.21 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing development of dmoads, rising demand for minimally invasive therapies, expansion of biologic and cell-based treatments, growing focus on personalized osteoarthritis care, increased investment in joint disease research. Major trends in the forecast period include increasing adoption of disease-modifying osteoarthritis therapies, rising use of regenerative medicine approaches, growing focus on non-opioid pain management, expansion of injectable and intra-articular treatments, enhanced emphasis on early disease intervention.

Global Osteoarthritis Therapeutics Market Segmentation

1) By Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids 2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies 3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route 4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs 5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses Subsegments: 1) By Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products 2) By Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors 3) By Analgesics: Non-Opioid Analgesics, Topical Analgesics 4) By Corticosteroids: Injectable Corticosteroids, Intra-Articular Corticosteroids

What Is The Driver Of The Osteoarthritis Therapeutics Market?

Rising sports injuries are expected to propel the growth of the osteoarthritis therapeutics market. A sports injury refers to any injury or harm that occurs during sports or athletic activities. These injuries can range in severity from small to severe, and they can affect various body parts. The increase in sports injuries is largely due to the rising participation in sports activities and the growing intensity and competitiveness of these activities. Osteoarthritis therapeutics are used in sports injuries to manage pain and inflammation and to improve joint function in athletes suffering from joint degeneration. For instance, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia, in 2023–24, about 62,100 sports injuries led to a hospital admission in Australia. Further, males accounted for 70% of all hospitalizations (or 43,800 cases), while females accounted for nearly 30% (or 18,300 cases). Therefore, rising sports injuries are driving the growth of the osteoarthritis therapeutics industry.

Key Players In The Global Osteoarthritis Therapeutics Market

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Galapagos NV, Regeneron Pharmaceuticals Inc., Samumed LLC, Kolon Life Science Inc., Horizon Therapeutics plc

Global Osteoarthritis Therapeutics Market Trends and Insights

Major companies operating in the osteoarthritis therapeutics market are focused on developing innovative solutions, such as novel innovations for tissue regeneration in osteoarthritis. Tissue regeneration in osteoarthritis refers to the process of repairing or replacing damaged cartilage and joint tissues to restore normal function and alleviate pain. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, launched the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO). The Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, initiated by the Advanced Research Projects Agency for Health (ARPA-H), focuses on developing cutting-edge injectable therapies that stimulate cartilage repair by leveraging biological pathways similar to those active during embryonic development. Unique features include a collaborative multimodal approach among research teams and advanced testing techniques such as "joint-on-a-chip" platforms to mimic joint environments, aiming to create regenerative solutions that address the underlying causes of osteoarthritis.

What Are Latest Mergers And Acquisitions In The Osteoarthritis Therapeutics Market?

In February 2025, Pacira BioSciences, a US-based biotechnology company, acquired GQ Bio Therapeutics for approximately US$32 million. Through this acquisition, Pacira aims to advance its osteoarthritis therapy pipeline by integrating GQ Bio’s high-capacity adenovirus (HCAd) gene therapy platform and progressing the development of PCRX-201 (enekinragene inzadenovec) for knee osteoarthritis. GQ Bio Therapeutics is a Germany-based biotech company that develops gene therapy vectors and osteoarthritis-targeted gene therapies.

Regional Outlook

North America was the largest region in the osteoarthritis therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Osteoarthritis Therapeutics Market?

The osteoarthritis therapeutics market consists of revenues earned by entities by providing services such as exercises and therapies, diagnostic services, and pain management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis therapeutics market also includes sales of pain relievers, corticosteroids, hyaluronic acid injections, and assistive devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Osteoarthritis Therapeutics Market Report 2026?

The osteoarthritis therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the osteoarthritis therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.